Co-Authors
This is a "connection" page, showing publications co-authored by MICHELLE A.T. HILDEBRANDT and CHAD HUFF.
Connection Strength
0.684
-
A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. HGG Adv. 2022 Jan 13; 3(1):100078.
Score: 0.212
-
XPAT: a toolkit to conduct cross-platform association studies with heterogeneous sequencing datasets. Nucleic Acids Res. 2018 04 06; 46(6):e32.
Score: 0.165
-
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. J Natl Cancer Inst. 2022 11 14; 114(11):1533-1544.
Score: 0.057
-
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy. Leukemia. 2022 Nov; 36(11):2669-2677.
Score: 0.056
-
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet. 2022 May; 30(5):630-631.
Score: 0.055
-
Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet. 2022 03; 30(3):349-362.
Score: 0.053
-
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer. J Med Genet. 2021 05; 58(5):305-313.
Score: 0.048
-
The somatic mutation landscape of premalignant colorectal adenoma. Gut. 2018 07; 67(7):1299-1305.
Score: 0.039